Keyphrases
Confidence Interval
100%
Prognostic Value
100%
Tumor Immune Microenvironment
100%
Early-stage Lung Cancer
100%
Lung Adenocarcinoma
66%
Immune Cells
66%
Lung Squamous Cell Carcinoma
66%
Clinical Characteristics
66%
Immune Parameters
66%
Immune Infiltration
66%
Significant Predictors
33%
Non-small Cell Lung Cancer (NSCLC)
33%
Risk of Death
33%
Cell Survival
33%
Adjusted Hazard Ratio
33%
Cox Regression
33%
Prognostic Significance
33%
Surgical Resection
33%
Smoking Status
33%
Cox Regression Model
33%
XCell
33%
RNA-seq Data
33%
Clinical Information
33%
I to
33%
Cancer Genome Atlas
33%
CD4+ T Helper Cells
33%
Cancer Outcomes
33%
CD20+ B Cells
33%
Additional Treatment
33%
Lung Cancer Survival
33%
Cytotoxic CD8+ T Cells
33%
Confounding Factors
33%
Tumor Purity
33%
Predictive Biomarker
33%
Decreased Risk
33%
Non-small Cell Lung Cancer Patients
33%
Resected NSCLC
33%
Sample-specific
33%
Tumor-infiltrating Immune Cells
33%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Immunocompetent Cell
100%
Tumor Immune Microenvironment
100%
Immune Cell Infiltration
75%
Malignant Neoplasm
50%
Neoplasm
50%
Proportional Hazards Model
50%
Lung Adenocarcinoma
50%
Squamous Cell Lung Carcinoma
50%
Hazard Ratio
25%
Non-Small Cell Lung Cancer
25%
Surgery
25%
B Cell
25%
T-Helper Cell
25%
CD8 Antigen
25%
Biological Marker
25%
Cytotoxic T-Cell
25%
CD20
25%
Lung Cancer Survival
25%
Cell Population
25%
Cell Survival
25%
Immunology and Microbiology
Immunocompetent Cell
100%
Immunity
100%
Immune Cell Infiltration
75%
Squamous Cell
50%
B Cell
25%
CD4
25%
T Helper Cell
25%
CD8
25%
CD20
25%
Cancer Survival
25%
Cell Population
25%
Cytotoxic T Cell
25%
Cell Survival
25%
Biochemistry, Genetics and Molecular Biology
Immunocompetent Cell
100%
Immunity
100%
Cell Survival
20%
B Cell
20%
CD4
20%
CD8
20%
Cytotoxic T Cell
20%
CD20
20%
T Helper Cell
20%
Cancer Survival
20%
Cell Infiltration
20%